This site is part of the Siconnects Division of Sciinov Group

This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.

ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR

Registration

Mar
2022

WHO launches guidance on digitally documenting SARS-CoV-2 test results

Test Result technical specifications and guidance document for countries and implementing partnersReadmore

Mar
2022

Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the European Union to Adolescents (Ages 12-17)

If granted, Nuvaxovidâ„¢ COVID-19 Vaccine (recombinant, adjuvanted) would be the first protein-based option for adolescents aged 12-17 years in EuropeReadmore

Mar
2022

Brii Bio Announces Strategic Partnership with Sinopharm to Advance Commercialization of Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China

The partnership will accelerate stockpiling, channel distribution and regional access of the amubarvimab/romlusevimab combinationReadmore

Mar
2022

Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older

Second booster dose is intended to offer increased protection against severe disease and hospitalization for individuals who are most vulnerableReadmore

Mar
2022

INDICAID® OTC COVID-19 Rapid Antigen At-Home Test Receives FDA EUA

PHASE Scientific’s COVID-19 Rapid Antigen At-Home Test Now Available Across the U.S.—Enabling the American Public to Perform the Test On-DemandReadmore

Mar
2022

Detecting COVID-19 using only a smartphone

esApp Health Limited (ASX:RAP) today announced positive results for a new novel cough audio-based COVID-19 screening test that only requires a smartphone.Readmore

Subscribe to our News & Updates